HALOZYME THERAPEUT earnings per share and revenue

RV7 earnings per share for the last quarter are 1.08 CHF whereas the estimation was 0.84 CHF which accounts for 28.12% surprise. Company revenue for the same period amounts to 245.83 M CHF despite the estimated figure of 213.70 M CHF. Estimated earnings per share for the next quarter are 1.04 CHF, and revenue is expected to reach 260.68 M CHF. Also watch annual changes over time to get a bigger picture of RV7 earnings per share and revenue dynamics.